Antimypertensive substituted imidazoles

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

514400, 548335, 548342, A61K 31415, C07D23364

Patent

active

046846590

ABSTRACT:
The invention provides compounds of the formula: ##STR1## wherein each of R.sub.1, R.sub.2 and R.sub.3, which can be the same or different, is hydrogen, chloro, bromo, fluoro, methyl, ethyl, methoxy, amino, hydroxy or nitro; R.sub.4 is hydrogen or alkyl of 1 to 7 carbon atoms; X is ##STR2## (R.sub.5 is hydrogen or hydroxy) and n is 1-4; and their non-toxic pharmaceutically acceptable acid addition salts. These compounds exhibit valuable pharmacological activity and are useful in the treatment of mammals, especially as anti-hypertensive agents. Furthermore, some of the compounds have proved to possess diuretic, .beta.-blocking activity and/or antithrombotic activity. The compounds may be made by a variety of methods and may be incorporated in pharmaceutical compositions also comprising a compatible pharmaceutically acceptable carrier.

REFERENCES:
patent: 3448108 (1969-06-01), Villani
patent: 4213994 (1980-07-01), Gebert et al.
patent: 4443466 (1984-04-01), Karjalainen et al.
patent: 4544664 (1985-10-01), Karjalainen et al.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Antimypertensive substituted imidazoles does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Antimypertensive substituted imidazoles, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antimypertensive substituted imidazoles will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-884060

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.